Touchlight is a biotechnology company focused on the development, commercialization and licensing of doggybone or dbDNA™ based therapeutics and technologies. Touchlight’s doggybone DNA is a novel, linear, synthetic DNA vector with a unique expression profile, produced using a revolutionary enzymatic technology. Touchlight’s ambition is to advance genetic medicines to improve the treatment of disease and to underpin the future of DNA with our technology.